18/10/2025
Neurofilament light chain (NfL) measurement has emerged as a key biomarker for the diagnosis, monitoring, and prediction of neurologic disorders in recent years.
The Spanish Society of Fibromyalgia and Chronic Fatigue Syndrome reported that NfL measurements help detect neuroaxonal injury in conditions such as multiple sclerosis (MS), Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and traumatic brain injury. http://ms.spr.ly/6187sNNIt